Product Details

LETIFEND lyophilisate and solvent for solution for injection for dogs

• MA holder: LETI Pharma, S.L.U.
• VM number: EU/2/16/195/001-008
• Territory: Northern Ireland
• Associated documents:
  • Available from EU Union Product Database
• Date of issue: 20/04/2016
• Authorisation route: Centralised
• Active substances:
  • Recombinant protein Q from Leishmania infantum MON-1
• Controlled drug: No
• Target species:
  • Dogs
• Distribution category: POM-V